Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12857/116070
Title: Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes
Authors: Trama, Annalisa
Badalamenti, Giuseppe
Baldi, Giacomo Giulio
Brunello, Antonella 
Caira, Morena
Drove, Nora
Marrari, Andrea
Palmerini, Emanuela
Vincenzi, Bruno
Dei Tos, Angelo Paolo 
Grignani, Giovanni
Keywords: Cancer registries;Epidemiology;European reference network;Histology;Incidence;Italian rare cancer network;Prevalence;Reference centres;Regional variability;Soft tissue sarcoma
Keywords Plus: RARE CANCERS;PRACTICE GUIDELINES;BURDEN;ADHERENCE;PATTERNS;QUALITY;CENTERS;EUROPE;ADULTS
Mesh headings: Sarcoma;Soft Tissue Neoplasms
Secondary Mesh headings: Humans;Italy;Patient Care;Registries
Issue Date: 2019
Publisher: ELSEVIER SCI LTD
Journal: Cancer epidemiology 
Abstract: 
Sarcomas are rare malignant neoplasms that develop from mesenchymal cells and include a heterogeneous and large group of histological subtypes that may occur at any anatomical site. Soft tissue sarcomas (STS), the focus of this review, account for ≈70‒80% of sarcomas and represent <1% of all cancers. The heterogeneity of STS applies to both their topography and morphology, and 5-year survival can vary widely depending on disease stage and the complex interplay between anatomical site and histology for different STS subtypes. The rarity and heterogeneity of STS, together with other factors, such as the lack of clinical expertise often lead to difficulties and delays in making an accurate diagnosis and to the inappropriate management of each STS subtype. Therefore, this group of cancers requires special attention and approaches to diagnosis and treatment. Epidemiological data on STS are limited, and concerns have been raised regarding accurate registration of STS in cancer registries, including issues related to details of the histotypes. This review provides an overview of the epidemiology of STS in Italy, focusing on data from the Italian Association of Cancer Registries (AIRTUM), and compares findings with those from other European countries. Based on these data, and considering that STS is among the most common group of rare cancers, the relevance of multidisciplinary care for STS patients through reference centres, clinical networks and collaborative disease-specific groups is discussed.
URI: http://hdl.handle.net/20.500.12857/116070
ISSN: 18777821
DOI: 10.1016/j.canep.2019.02.012
Appears in Collections:Articles

Show full item record

PubMed Central
Citations 50

5
Last Week
0
Last month
0
checked on Aug 8, 2021

WEB OF SCIENCETM
Citations

5
checked on Dec 4, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.